Stifel Reiterates Buy Rating on Colfax Corporation (CFX) Following Healthcare Conference
Tweet Send to a Friend
Stifel analyst Nathan Jones reiterated a Buy rating and $37.00 price target on Colfax Corporation (NYSE: CFX) after meeting with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
